Skip to main content

887 publications

Name Date Type Actions

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

Public releases

Monthly information regarding the total number of voting rights – February 2024

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Monthly information regarding the total number of voting rights – January 2024

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Buyback programs – January 2024

Monthly communication regarding buyback programs

Description of buyback programs

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

Public releases

Monthly information regarding the total number of voting rights – December 2023

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

Agenda

Buyback programs - November 2023

Monthly communication regarding buyback programs

Description of buyback programs

Buyback programs - december 2023

Monthly communication regarding buyback programs

Description of buyback programs

Buyback programs - october 2023

Monthly communication regarding buyback programs

Description of buyback programs